SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice

Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2692315. doi: 10.21203/rs.3.rs-2692315/v1.

Abstract

We report the direct comparison of monomeric, dimeric and trimeric RBD protein subunit vaccines to a virus-like particle (VLP) displaying RBD. After two and three doses, a RBD dimer and trimer elicited antibody levels in mice comparable to an RBD-VLP. Furthermore, an Omicron (BA.1) RBD hetero-dimer induced neutralizing activity similar to the RBD-VLP. A RBD hetero-dimer and RBD-VLP also shows comparable breadth to other SARS-CoV-2 variants-of-concern (VOCs).

Publication types

  • Preprint